
Advancing risk-based auditing one step further by identifying the underlying process deficiencies to enable improved corrective and preventive actions.
Director, North and South America, Clinical TrialSystem and Auditing QA, RDQ, Bristol Myers Squibb

Advancing risk-based auditing one step further by identifying the underlying process deficiencies to enable improved corrective and preventive actions.